908 Devices Inc. (NASDAQ:MASS) CEO Kevin J. Knopp Buys 10,000 Shares

908 Devices Inc. (NASDAQ:MASS) CEO Kevin J. Knopp purchased 10,000 shares of the business’s stock in a transaction on Thursday, May 9th. The shares were bought at an average price of $5.83 per share, for a total transaction of $58,300.00. Following the purchase, the chief executive officer now directly owns 488,981 shares in the company, valued at approximately $2,850,759.23. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

908 Devices Trading Up 1.1 %

Shares of MASS stock traded up $0.06 during trading hours on Thursday, hitting $5.76. The company’s stock had a trading volume of 451,852 shares, compared to its average volume of 181,132. The company has a 50 day moving average of $6.41 and a 200 day moving average of $7.07. The stock has a market cap of $189.96 million, a PE ratio of -5.33 and a beta of 1.02. 908 Devices Inc. has a 12-month low of $4.85 and a 12-month high of $12.51.

908 Devices (NASDAQ:MASS) last posted its quarterly earnings results on Tuesday, April 30th. The company reported ($0.33) earnings per share for the quarter, topping the consensus estimate of ($0.36) by $0.03. The firm had revenue of $9.99 million for the quarter, compared to the consensus estimate of $9.29 million. 908 Devices had a negative net margin of 68.57% and a negative return on equity of 20.47%. The company’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same period last year, the firm posted ($0.39) earnings per share. As a group, analysts anticipate that 908 Devices Inc. will post -1.11 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in MASS. AWM Investment Company Inc. acquired a new position in shares of 908 Devices in the third quarter valued at approximately $3,740,000. ARK Investment Management LLC grew its holdings in shares of 908 Devices by 8.3% in the fourth quarter. ARK Investment Management LLC now owns 4,346,579 shares of the company’s stock valued at $48,769,000 after purchasing an additional 333,119 shares in the last quarter. Iron Triangle Partners LP grew its holdings in shares of 908 Devices by 31.1% in the fourth quarter. Iron Triangle Partners LP now owns 1,284,947 shares of the company’s stock valued at $14,417,000 after purchasing an additional 304,484 shares in the last quarter. Granahan Investment Management LLC grew its holdings in shares of 908 Devices by 10.6% in the fourth quarter. Granahan Investment Management LLC now owns 2,038,658 shares of the company’s stock valued at $22,874,000 after purchasing an additional 195,368 shares in the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. grew its holdings in 908 Devices by 3.0% during the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 629,994 shares of the company’s stock worth $4,196,000 after acquiring an additional 18,492 shares in the last quarter. Institutional investors and hedge funds own 88.06% of the company’s stock.

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.